IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CROSIGNANI, PIERGIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.946
NA - Nord America 7.066
AS - Asia 6.682
SA - Sud America 555
AF - Africa 132
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 22.442
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.826
GB - Regno Unito 3.112
SG - Singapore 1.982
CN - Cina 1.981
SE - Svezia 1.029
RU - Federazione Russa 792
IT - Italia 787
VN - Vietnam 592
DE - Germania 576
HK - Hong Kong 560
BR - Brasile 366
FR - Francia 346
TR - Turchia 325
KR - Corea 308
IN - India 302
UA - Ucraina 302
NL - Olanda 253
IE - Irlanda 233
BD - Bangladesh 219
FI - Finlandia 185
EU - Europa 169
CA - Canada 157
ID - Indonesia 84
CO - Colombia 72
JP - Giappone 66
AR - Argentina 50
ES - Italia 49
PL - Polonia 47
GR - Grecia 43
MX - Messico 41
AU - Australia 40
BE - Belgio 34
PH - Filippine 34
IQ - Iraq 28
PK - Pakistan 28
CI - Costa d'Avorio 27
ZA - Sudafrica 26
AT - Austria 25
EC - Ecuador 21
MY - Malesia 21
TH - Thailandia 21
IR - Iran 18
SA - Arabia Saudita 17
TW - Taiwan 17
CL - Cile 16
MA - Marocco 14
PT - Portogallo 14
CZ - Repubblica Ceca 13
EG - Egitto 13
NG - Nigeria 12
NO - Norvegia 12
RO - Romania 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
HU - Ungheria 10
PE - Perù 9
DK - Danimarca 8
JM - Giamaica 8
KE - Kenya 8
NZ - Nuova Zelanda 8
UY - Uruguay 8
AZ - Azerbaigian 7
BG - Bulgaria 7
HN - Honduras 7
JO - Giordania 7
LT - Lituania 7
RS - Serbia 7
TN - Tunisia 7
BO - Bolivia 6
EE - Estonia 6
ET - Etiopia 6
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
IS - Islanda 4
LU - Lussemburgo 4
LV - Lettonia 4
PY - Paraguay 4
BY - Bielorussia 3
DZ - Algeria 3
IL - Israele 3
KW - Kuwait 3
MD - Moldavia 3
MM - Myanmar 3
OM - Oman 3
SV - El Salvador 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AM - Armenia 2
BF - Burkina Faso 2
BH - Bahrain 2
BN - Brunei Darussalam 2
ER - Eritrea 2
Totale 22.564
Salva come PNG Salva come JPEG
Città #
Southend 2.858
Singapore 1.248
Chandler 533
Hong Kong 519
Ashburn 468
Seattle 465
San Jose 404
Beijing 382
Princeton 323
Wilmington 290
Dublin 228
Santa Clara 225
Milan 223
Council Bluffs 218
Redmond 212
Dallas 204
Jacksonville 196
Los Angeles 179
Houston 178
Ann Arbor 161
Mountain View 159
Boardman 150
Nanjing 148
Ho Chi Minh City 137
Sakarya 135
Lauterbourg 134
Woodbridge 133
Fairfield 125
Bengaluru 122
Hanoi 119
Des Moines 111
Buffalo 105
Moscow 102
Dearborn 99
New York 84
The Dalles 82
Guangzhou 80
Jinan 75
Berlin 70
Shanghai 70
Serra 69
Dong Ket 64
Columbus 61
Shenyang 61
Redwood City 60
Bogotá 59
Toronto 59
Andover 58
Tianjin 54
Nanchang 53
Tokyo 49
Cangzhou 46
Falls Church 46
Somerville 46
Phoenix 45
Changsha 44
São Paulo 43
Hefei 42
Cambridge 41
Pisa 38
Shenzhen 37
Frankfurt am Main 35
Eitensheim 34
Hebei 34
Warsaw 33
Helsinki 32
Ottawa 32
Washington 31
Bitonto 30
Jakarta 30
Chicago 29
San Diego 29
Bangalore 28
Rome 26
Abidjan 25
Da Nang 25
Seoul 25
Zhengzhou 25
Brussels 24
Hangzhou 24
Athens 23
Ningbo 23
Mumbai 21
Fuzhou 19
Haiphong 18
Kunming 18
Munich 18
Auburn Hills 17
Pune 17
Atlanta 16
Jiaxing 16
Kent 15
London 15
Redondo Beach 15
Sunnyvale 15
Taizhou 15
Brooklyn 14
Chengdu 14
Haikou 13
Hanover 13
Totale 13.715
Salva come PNG Salva come JPEG
Nome #
Progestogens for endometriosis : forward to the past 983
Bone fractures after menopause 650
Simultaneous prevention of unintended pregnancy and STIs: A challenging compromise 425
Endometriosis: current and future medical therapies 315
Hormones and cardiovascular health in women 270
Breast cancer risk with postmenopausa hormonal treatment 260
Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure 248
Endometriosis: current therapies and new pharmacological developments 246
Surgery for endometriosis-associated infertility : a pragmatic approach 243
The use and effectiveness of in vitro fertilization in women with endometriosis : the surgeon's perspective 236
Effect of the ethinylestradiol/norelgestromin contraceptive patch on body composition. Results of bioelectrical impedance analysis in a population of Italian women 232
Postoperative oral contraceptive exposure and risk of endometrioma recurrence 227
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort : a nested case-control study 224
Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms : a multivariate analysis of over 1000 patients 211
Fertility and ageing 210
Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen 208
Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy : a controlled trial 207
Endometrial bleeding 205
Reproductive performance in infertile women with rectovaginal endometriosis: Is surgery worthwhile? 205
The effect of surgery for symptomatic endometriosis: the other side of the story 204
Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate 201
Female contraception over 40 201
Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: A multicenter, randomized, double-blind study 201
Fibroids and female reproduction : a critical analysis of the evidence 199
Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy 196
Asymmetry in distribution of diaphragmatic endometriotic lesions: evidence in favour of the menstrual reflux theory 192
Endometriosis: preoperative and postoperative medical treatment 191
Waiting for Godot : a commonsense approach to the medical treatment of endometriosis 191
Menstrual characteristics in women with and without endometriosis 190
Deep endometriosis: definition, pathogenesis, and clinical management 186
Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility 186
Progestinici ed endometriosi 184
Deep endometriosis conundrum: evidence in favor of a peritoneal origin 184
Abdominal myomectomy for infertility: a comprehensive review 182
Endometriosis and pelvic pain: relation to disease stage and localization 182
A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study 180
Lateral distribution of recurrent ovarian endometriotic cysts 179
Surgical management of endometriosis 176
Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study 175
Advances in the management of endometriosis : an update for clinicians 175
Analysis of p53 and ras gene mutations in endometriosis 175
Evidence for asymmetric distribution of lower intestinal tract endometriosis 172
Nutrition and reproduction in women 172
Effectiveness of sonohysterography in infertile patient work-up : a comparison with transvaginal ultrasonography and hysteroscopy 169
Randomized comparison of vaporizing electrode and cutting loop for endometrial ablation 168
Gynaecological endocrinology 167
Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain 166
Venous thromboembolism in women : a specific reproductive health risk 163
Damage to ovarian reserve associated with laparoscopic excision of endometriomas : a quantitative rather than a qualitative injury 162
Non-invasive diagnosis of endometriosis: the goal or own goal? 159
A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis 159
Noncontraceptive health benefits of combined oral contraception 158
Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea 157
Adenomyosis: a déjà vu? 156
Is ureteral endometriosis an asymmetric disease? 155
Reply: Oral contraceptives and the endometriosis domino effect 154
Leuprolide in a 3-monthly versus a monthly depot formulation for the treatment of symptomatic endometriosis: a pilot study 154
Looking to Europe: something's changed in Italy 153
Circatrigintan rectal temperature and endocrine rhythms of clinically healthy, menstrually cycling women 152
IVF, from the past to the future: the inheritance of the Capri Workshop Group 152
Site of origin of epithelial ovarian cancer: the endometriosis connection 150
Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: a multicentre, randomised controlled trial 149
Why after 50 years of effective contraception do we still have unintended pregnancy? A European perspective 149
Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulaton syndrome 148
Abnormal uterine bleeding associated with iron-deficiency anemia. Etiology and role of hysteroscopy 148
Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis 147
A modified technique for correction of the complete septate uterus 147
Does laparoscopic removal of nonendometriotic benign ovarian cysts affect ovarian reserve? 146
Current treatment issues in female hyperprolactinaemia 145
Evidence for asymmetric distribution of sciatic nerve endometriosis 145
The incessant menstruation hypothesis : a mechanistic ovarian cancer model with implications for prevention 145
Is cystic ovarian endometriosis an asymmetric disease? 144
Genetic aspects of female reproduction 142
Anthropometric indicators and response to gonadotrophin for ovulation induction 142
Hormonal contraception without estrogens 142
Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis : results of a randomized, controlled trial 141
Goserelin (Zoladex) and the anaemic patient 141
Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics 141
Should endometriomas be treated before IVF-ICSI cycles? 140
Progestins for symptomatic endometriosis: a critical analysis of the evidence 140
Veralipride for hot flushes during gonadotropin-releasing hormone agonist treatment 138
Medical treatment for rectovaginal endometriosis : what is the evidence? 137
Video display terminal use during pregnancy and reproductive outcome--a meta-analysis 137
Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis : the predictive value of the current classification system 135
Lateral distribution of nonendometriotic benign ovarian cysts 134
Metroplasty for the complete septate uterus: does cervical sparing matter? 134
Endometriosi 133
Does a “peritoneal circulation” really exists? 132
A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis 131
Health and fertility in World Health Organization group 2 anovulatory women 131
Hysterectomy for benign gynecologic disorders - When and why? 130
Towards a more pragmatic and wiser approach to infertility care 130
Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study 128
Semen preparation by standard swim-up versus swim-up with test yolk buffer incubation in intrauterine insemination: a randomized study 128
Minimal and mild endometriosis. Is there anything new under the sun? 128
Current treatment issues in female hyperprolactinemia 127
Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis 127
Clinical overview of hormonal contraception with special emphasis on long-term effects 127
Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years’ experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. 126
Transvaginal ultrasonography versus uterine needle biopsy in the diagnosis of diffuse adenomyosis 125
Totale 18.493
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021237 0 0 0 0 0 0 0 0 0 0 0 237
2021/20221.468 147 51 43 123 100 119 118 82 101 142 163 279
2022/20231.981 267 208 156 251 232 413 26 122 165 26 62 53
2023/2024949 49 86 33 32 184 60 45 72 16 81 142 149
2024/20252.658 84 224 46 274 299 143 47 356 174 229 252 530
2025/20266.026 591 296 630 522 745 481 707 401 701 385 453 114
Totale 23.622